Lung cancer is the leading cause of cancer-related deaths worldwide, with approximately 80% of cases linked to cigarette smoking. What makes it particularly dangerous is how silently it develops as most people experience no symptoms in the early stages, and by the time symptoms do appear, the disease has often already advanced to a late stage where treatment options are limited. For heavy smokers, the risk is significantly elevated, making early detection not just beneficial but potentially life-saving.
Currently, low-dose CT (LD-CT) scanning is the standard tool for lung cancer screening for smokers, yet fewer than 5% of eligible Americans actually get screened each year. Barriers like cost, limited access, radiation concerns, and inconvenience keep millions of high-risk individuals from getting the screening they need. This gap is exactly why lung cancer screening for smokers is focused on finding simpler, more accessible alternatives, like a blood test that can be integrated into routine medical care and reach people before the disease progresses
Our team is conducting detection for lung cancer clinical trial in Oklahoma City, OK to evaluate the efficacy and safety of investigational therapies, offering hope for improved care and outcomes.
Joining the clinical trial is entirely voluntary and comes at no cost.
To find out more about lung cancer detection research, simply complete the form above.
